Pershing Square Announces New Position in Valeant Pharmaceuticals International

AMSTERDAM--(BUSINESS WIRE)-- Regulatory News:

Pershing Square Holdings, Ltd. (ticker: PSH:NA) announced today a new position in Valeant Pharmaceuticals International, Inc. (ticker: NYSE: VRX) representing approximately 16.9% of the PSH portfolio (based on the closing NAV of PSH and the closing share price of VRX on Friday, 6 March 2015).

Pershing Square Capital Management, L.P., the investment manager for Pershing Square Holdings, Ltd., announced that various funds it manages have purchased 16,473,933 shares of Valeant Pharmaceuticals International, Inc., representing 4.9% of Valeant.

About Pershing Square Holdings, Ltd.

Pershing Square Holdings, Ltd. is a concentrated, research‐intensive, fundamental value investor in the public markets.

MEDIA CONTACTS
StockWell Communications
Tim Burt, +44 (0)20 7240 2486
[email protected]

Source: Pershing Square Holdings, Ltd.

You May Also Be Interested In

• CORRECTION FROM SOURCE: Myriad Uranium Announces Preliminary Radiometric Results from Lucky Cliff Drilling
• The National carrier of the Hashemite Kingdom of Jordan, Royal Jordanian Airlines Selects Ramco Systems to Power Its Next Phase of Growth
• Form 8.5 (EPT/RI) - CAB Payments Holdings Plc